AC Immune Inc (ACIU): Prakiraan rega marang bathi
AC Immune management is focused on developing high-precision tools for the therapy and detection of Parkinson's and Alzheimer's pathologies through strategic alliances. The operating model relies on engaging external certified organizations to conduct drug trials, which minimizes internal costs. The current P/E ratio is 7.00, as clearly demonstrated by this market valuation chart.
Rincian metrik lan analitis perusahaan AC Immune Inc (ACIU)
- kuotasi lan prakiraan analis:
- data kapitalisasi bursa:
- statistik nilai buku emiten:
- indikator beban utang lan likuiditas:
Utang marang Ekuitas AC Immune|ACIU - Rasio utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas AC Immune|ACIU - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku AC Immune S.A.|ACIU - Tanggungan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan AC Immune|Rasio cepet acimmune.com
- statistik bathi lan rasio pasar:
ACIU - Bathi resik|Proyeksi bathi mangsa ngarep AC Immune|ACIU - Koefisien rega marang bathi|Pangali Forward P/E AC Immune Corp|ACIU - Kapitalisasi marang bathi resik kanthi nimbang wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan AC Immune S.A.|ACIU - Bathi operasional EBITDA|Bathi saben saham sajrone rolas wulan pungkasan AC Immune|ACIU - Bathi saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan acimmune.com|ACIU - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep AC Immune
Analisis komprehensif perusahaan:ACIU AC Immune SA
AC Immune is recruiting leading neurobiologists to develop Alzheimer's disease therapies. By analyzing the company's current forward P/E, an investor can determine the business's market value relative to its projected earnings. This metric aggregates the weighted probabilities of future income, reflecting the market's level of optimism. A deviation from the mean signals that the asset is overheated, while low indicators necessitate caution to avoid investing in a loss-making business.
Karo sapa AC Immune saingan
Pangali Forward P/E BIIB|Prakiraan rega marang bathi Neurocrine NBIX|Regencell - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi AXSM|ACADIA Pharmaceuticals - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi xenon-pharma.com XENE|Viking Therapeutics, Inc. (VKTX) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi Supernus Pharmaceuticals, Inc.|Rega marang bathi mangsa ngarep Catalyst Pharmaceuticals Inc|Prakiraan rega marang bathi Denali Corp (DNLI)|Prakiraan rega marang bathi HRMY (Harmony Biosciences)|Pangali Forward P/E biohavenpharma.com (BHVN)|Rega marang bathi mangsa ngarep Amylyx Pharmaceuticals, Inc. AMLX|TRVI: Rasio rega marang bathi mangsa ngarep|Praxis Medicines - Pangali Forward P/E|Rasio prakiraan rega marang bathi Anavex Life Sciences Corp|CBLL: Pangali Forward P/E|Prothena (PRTA) - Pangali Forward P/E|ALEC (Alector Inc.) - Pangali Forward P/E|Prakiraan rega marang bathi Annexon Biosciences (ANNX)|Pangali Forward P/E OMER|Kapitalisasi marang proyeksi bathi Neurogene Therapeutics|Voyager Therapeutics - Prakiraan rega marang bathi|Pangali Forward P/E neumoratx.com NMRA|SCLX - Rega marang bathi mangsa ngarep|TVGN (Tevogen Bio Holdings Inc.) - Rasio rega marang bathi mangsa ngarep|ACOG: Pangali Forward P/E|Rasio prakiraan rega marang bathi Cognition Therapeutics Inc. (CGTX)|Prakiraan rega marang bathi IKT|Pangali Forward P/E cassavasciences.com|Rega marang bathi mangsa ngarep Assertio Holdings, Inc. (ASRT)|COYA (coyatherapeutics.com) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Vistagen VTGN|Ovid Therapeutics Inc (OVID) - Rasio prakiraan rega marang bathi|Acumen Pharmaceuticals - Pangali Forward P/E|CRVO - Pangali Forward P/E|ATHE: Pangali Forward P/E|Prakiraan rega marang bathi Clene|Prakiraan rega marang bathi PEPG|JUNS: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E RLMD|Kapitalisasi marang proyeksi bathi annovisbio.com|Rega marang bathi mangsa ngarep Grace Therapeutics GRCE|AIFF - Prakiraan rega marang bathi|KLTO - Rega marang bathi mangsa ngarep|NeuroSense Therapeutics (NRSN) - Prakiraan rega marang bathi|RVPH (Reviva Pharmaceuticals) - Prakiraan rega marang bathi|MetaVia (MTVA) - Pangali Forward P/E|Rega marang bathi mangsa ngarep NeurAxis|Rasio rega marang bathi mangsa ngarep HSDT (Helius Medical Technologies Inc.)|Pangali Forward P/E PASG|NEUP - Rasio prakiraan rega marang bathi|Pangali Forward P/E NERV (Minerva Neurosciences)|Pangali Forward P/E athira.com ATHA|Addex Therapeutics Ltd - Pangali Forward P/E|Alzamend Neuro, Inc. (ALZN) - Prakiraan rega marang bathi|CYCN: Pangali Forward P/E|PTIX - Kapitalisasi marang proyeksi bathi|Prakiraan rega marang bathi KTTA|Pangali Forward P/E Cortigent Medical|Rega marang bathi mangsa ngarep Avenue Therapeutics, Inc. (ATXI)|Brainstorm Cell Therapeutics Inc. - Rasio rega marang bathi mangsa ngarep|Pangali Forward P/E CARA (Cara Therapeutics, Inc)|Chromocell (CHRO) - Rasio prakiraan rega marang bathi|ELYM: Prakiraan rega marang bathi|ITCI - Pangali Forward P/E|Longboard Pharmaceuticals, Inc. (LBPH) - Rega marang bathi mangsa ngarep|Marinus Pharmaceuticals Inc - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep NKGen|Rasio prakiraan rega marang bathi NeuroBo Pharma NRBO|Pangali Forward P/E SAGE|Pangali Forward P/E synaptogen.com (SNPX)|Pangali Forward P/E TRVN (Trevena)|VIGL - Prakiraan rega marang bathi|WENA: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi CERE (Cerevel Corp)
